Showing results for "the promise" in Medicine & Health Care Industry

BPC-157: The Promise and Perils of a Healing Peptide is a clear-eyed exploration of one of the most talked-about compounds in modern recovery and biohacking. Originally studied for its potential effects on tissue repair and gut health, BPC-157 has drawn attention for its reported ability to support tendon healing, inflammation reduction, and recovery. While promising animal research has fueled interest, the absence of large-scale human trials leaves important questions about safety, regulation, and long-term effects.

Scientists and genetic engineers are becoming increasingly adept at editing the human genome. How far can—and should—they go in editing future generations? In The Promise and Peril of CRISPR, editor Neal Baer brings together a timely collection of essays by influential bioethicists, philosophers, and geneticists to explore the moral, ethical, and policy challenges posed by CRISPR technology.

What began as a simple promise became an entrepreneurial journey to change an industry. In A Culture of Promise: The True Story of a Small Company’s Quest to Transform the Senior Living Industry, author Fee Stubblefield encapsulates the best insights on how to build an organization from the ground up and the challenges and opportunities the senior living industry as a whole faces. Even if you aren’t in senior living you will want to listen to this book because every family and every sector of the economy and government is touched and impacted by our country’s rapidly aging population.

For nearly a decade, Jackie watched over her father's care. She quickly found her world filled with adult diapers, a pharmacy of pills, and days heavily laced in utter boredom. As the days melted together, Jackie came to understand what her father was teaching her - how to live in constant gratitude and with a heart full of love.

Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.